<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01544608</url>
  </required_header>
  <id_info>
    <org_study_id>NIS-NME-XXX-2011/1</org_study_id>
    <nct_id>NCT01544608</nct_id>
  </id_info>
  <brief_title>Observe Real-life Allocation of Atypical Antipsychotics in the Acute Inpatient Management of Schizophrenia</brief_title>
  <acronym>RECONNECT-S</acronym>
  <official_title>A Non- Interventional Study to Observe Real Life Usage of Atypical Antipsychotics in the Acute Inpatient Management of Schizophrenia.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>AstraZeneca</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>AstraZeneca</source>
  <brief_summary>
    <textblock>
      The primary objective of this Non- Interventional Study (NIS) is to describe the use of
      atypical antipsychotics in subjects with Schizophrenia during the hospitalisation due to
      acute psychotic episode by evaluation of drug, dose and mode of administration of the
      medication.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      RECONNECT-S BETA
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>July 2012</start_date>
  <completion_date type="Actual">December 2012</completion_date>
  <primary_completion_date type="Actual">December 2012</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Use of atypical antipsychotic(s) during hospitalisation.</measure>
    <time_frame>Hospitalisation period, an expected average of 3 weeks (variable per patient).</time_frame>
    <description>The data will be collected at one visit at the moment of discharge from the hospital.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Daily dosage of atypical antipsychotic(s) during hospitalisation.</measure>
    <time_frame>Hospitalisation period, an expected average of 3 weeks (variable per patient).</time_frame>
    <description>The data will be collected at one visit at the moment of discharge from the hospital.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Mode of administration of atypical antipsychotic(s) during hospitalisation.</measure>
    <time_frame>Hospitalisation period, an expected average of 3 weeks (variable per patient).</time_frame>
    <description>The data will be collected at one visit at the moment of discharge from the hospital.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Percent of patients with atypical antipsychotic as monotherapy.</measure>
    <time_frame>Hospitalisation period, an expected average of 3 weeks (variable per patient).</time_frame>
    <description>The data will be collected at one visit at the moment of discharge from the hospital.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Percent of patients with combinations of antipsychotics.</measure>
    <time_frame>Hospitalisation period, an expected average of 3 weeks (variable per patient).</time_frame>
    <description>The data will be collected at one visit at the moment of discharge from the hospital.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Main criteria of an antipsychotic's selection during hospitalisation expressed as percentage.</measure>
    <time_frame>Hospitalisation period, an expected average of 3 weeks (variable per patient).</time_frame>
    <description>The data will be collected at one visit at the moment of discharge from the hospital.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Use of psychometric scales in day to day practice in therm of evaluation of the disease symptoms and thus efficacy of the treatment.</measure>
    <time_frame>Hospitalisation period, an expected average of 3 weeks (variable per patient).</time_frame>
    <description>The data will be collected at one visit at the moment of discharge from the hospital.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Description of the usage of concomitant psychiatric medication (other than atypical antipsychotic) during the hospitalization.</measure>
    <time_frame>Hospitalisation period, an expected average of 3 weeks (variable per patient).</time_frame>
    <description>The data will be collected at one visit at the moment of discharge from the hospital.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Relationship between medication used during the hospitalization and maintenance therapy recommended upon discharge.</measure>
    <time_frame>Hospitalisation period, an expected average of 3 weeks (variable per patient).</time_frame>
    <description>The data will be collected at one visit at the moment of discharge from the hospital.</description>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Actual">1076</enrollment>
  <condition>Schizophrenia</condition>
  <arm_group>
    <arm_group_label>Subjects who are hospitalized due to acute psychotic episode.</arm_group_label>
    <description>All subjects who are hospitalized due to acute psychotic episode. The subjects should be managed according to normal clinical practice until discharge time.</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        Psychiatric Institutes
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Meet the diagnostic criteria for schizophrenia stated in The Diagnostic and
             Statistical Manual of Mental Disorders, 4th edition (DSM-IV) criteria.

          -  Subject is hospitalised due to an acute psychotic episode.

          -  Ability of the subject to understand and comply with the requirements of the study, as
             judged by the investigator.

        Exclusion Criteria:

          -  Current participation in any clinical trial.

          -  Previous enrolment in the present NIS (in case of recurrence occurred during the
             enrolment period).
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Talaat Matar, CONSULTANT PSYCHIATRIST</last_name>
    <role>Study Chair</role>
    <affiliation>Obaid Alla Hospital,Ras Al Khaima,UAE</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Tarek Darwish, CONSULTANT PSYCHIATRIST</last_name>
    <role>Study Chair</role>
    <affiliation>Sheikh Khalifa Medical City(SKMC), Abudhabi,UAE</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Sohail Khan, CONSULTANT PSYCHIATRIST</last_name>
    <role>Study Chair</role>
    <affiliation>Jeddah Psychiatric hospital,Jeddah, Saudi Arabia</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Tarek Okasha, PROFESSOR</last_name>
    <role>Study Chair</role>
    <affiliation>Ain Shams University, Cairo, Egypt</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Mohamed Nasr, PROFESSOR</last_name>
    <role>Study Chair</role>
    <affiliation>Cairo University, Egypt</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Research Site</name>
      <address>
        <city>Cairo</city>
        <country>Egypt</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Research Site</name>
      <address>
        <city>Dammam</city>
        <country>Saudi Arabia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Research Site</name>
      <address>
        <city>Jeddah</city>
        <country>Saudi Arabia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Research Site</name>
      <address>
        <city>Riyadh</city>
        <country>Saudi Arabia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Research Site</name>
      <address>
        <city>Abu Dhabi</city>
        <country>United Arab Emirates</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Research Site</name>
      <address>
        <city>Dubai</city>
        <country>United Arab Emirates</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Research Site</name>
      <address>
        <city>Ras Al Khaimah</city>
        <country>United Arab Emirates</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Egypt</country>
    <country>Saudi Arabia</country>
    <country>United Arab Emirates</country>
  </location_countries>
  <verification_date>June 2013</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 20, 2012</study_first_submitted>
  <study_first_submitted_qc>February 29, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 6, 2012</study_first_posted>
  <last_update_submitted>June 19, 2013</last_update_submitted>
  <last_update_submitted_qc>June 19, 2013</last_update_submitted_qc>
  <last_update_posted type="Estimate">June 20, 2013</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Acute psychotic episode of Schizophrenia</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Schizophrenia</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Antipsychotic Agents</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

